Official Title
Long-term Outcomes in Patients With COVID-19
Brief Summary

Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.

Detailed Description

The ongoing pandemic of coronavirus disease 2019 (COVID-19), due to the newly discovered
severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2), has caused a worldwide increase
in hospitalization for pneumonia with multi- organ disease. Survival from sepsis is
associated with increased risk for mortality for at least 2 years. Therefore, substantial
sequelae including new physical disability, new cognitive impairment and increased
vulnerability to further health deterioration are likely to be seen in survivors of COVID-19.
The investigators conduct this study to investigate daily living status of survivors of
COVID-19 using telephone interview questionnaire including Activity Daily Living(ADL),
modified Medical Research Council(mMRC),modified Telephone Interview for Cognitive Status
(TICS-m), Zung Self-rating Depression Scale(SDS), Carcinologic Handicap Index (CHI), and New
York Heart Association (NYHA) functional class.

Unknown status
COVID-19
Eligibility Criteria

Inclusion Criteria:

- Survivors who had been admitted in Leishenshan Hospital for COVID-19 patients in
Wuhan, China

Exclusion Criteria:

- Patients who were < 18 years

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
China
Locations

Renji Hospital, Shanghai Jiaotong University School of Medicine
Pudong, Shanghai, China

Investigator: Diansan Su, MD,PhD
Contact: 8618616514088
diansansu@yahoo.com

Contacts

Diansan Su, MD,PhD
+8618616514088
diansansu@yahoo.com

Weifeng Yu, MD,PhD, Study Director
Renji Hospital, School of Medicine, Shanghai Jiaotong University, China

RenJi Hospital
NCT Number
Keywords
Covid-19
long-term outcomes
MeSH Terms
COVID-19